Rezultati pretraživanja

  1. Osobe Vidi sve

  2. prije 26 minuta

    Of course that’s only the beginning because then a price is set for the value of sublicense to other parties, which can be monetized through deals or litigation. More earnings for /2

    Odgovor korisniku/ci @srqstockpicker
    So, my read is they got stock for a dollar a share times perhaps 3.6M shares. If stock hit 20 on day 1 that’s a $108M again for and then earnings start to swell when takes the options./1
  3. prije 6 sati

    What stock do you believe could become a large cap over time? , ,

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
  4. prije 11 sati

    0038 THE MONSTER AWAKENING WATCHING?! cancer use ur eyes👀

  5. prije 16 sati

    Insider Selling: Editas Medicine Inc Insider Sells 5,549 Shares of Stock

  6. prije 18 sati

    Charles Albright Dumps 5.5K Shares of Editas Medicine, Inc.

    1 proslijeđeni tweet
  7. prije 18 sati

    : New Insider Filing on Chief Scientific Officer CHARLES ALBRIGHT:

  8. 3. velj

    Hammer candles detected:

    1 proslijeđeni tweet
  9. 3. velj

    Simple and public, the value of has risen so far that their compliance department requires sales. Meanwhile they buy gene editing biotech companies which are oversold. And, hey Can you show a 'lil respect for the winner?

    If Wild Cathie from ARK invest has that ludicrous price target on Tesla then why are they selling shares today? Reminds of the time when CNBC asked ceo why he was selling shares and he just laughed
  10. 3. velj

    "Apple is worth over one trillion dollars today and while they make great products, they are not curing cancer." I bought and this morning. In the next 10 years, these three companies can fundamentally improve human life expectancy and quality.

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
  11. 3. velj

    Evercore ISI downgraded to an In Line rating, $52 PT

    5 proslijeđenih tweetova 7 korisnika označava da im se sviđa
  12. 3. velj

    Expecting huge recovery on oversold beaten down best in class and most promising Will only get higher from here if coronavirus stays relatively contained in US and outside China. and small plays in , data expected

    1 korisnik označava da mu se sviđa
  13. 31. sij

    Staying long 5 years

    2 korisnika označavaju da im se sviđa
  14. 30. sij

    Long health care -telehealth platform Doctors face time is the future -tumor testing Testing get breakthrough -Gene editing The code for all cure -disposable robotics Clean and fixed form inside the body -informatics lab pediatric and rare diseases

    1 reply 2 korisnika označavaju da im se sviđa

Nema rezultata.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.